Komori
ReproCELL (4978) · RiskRestated

Risk of inadequate management oversight following delegation of authority to overseas subsidiaries

First written in FY2017. 2 of 4 entries say "Restated". Latest entry: FY2026.

4entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017RestatedFY2021 – FY20262017: 120172018: 020182019: 020192020: 120202021: 120212022: 020222023: 020232024: 020242025: 020252026: 12026
Same theme, other companies
Internal Controls and Business Execution Monitoring Framework for SubsidiariesA theme 325 companies write about · 17 as a headwind · 312 as a tailwind

127 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 331 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「As the foundation of our system for ensuring that subsidiaries conduct their operations appropriately, each company generally holds a board meeting once a month, as well as extraordinary board meetings as necessary.」

    The company has reaffirmed its management framework for the group, including overseas subsidiaries, comprising monthly board meetings at each company, monthly financial reporting, overseas dispatches, J-SOX audits and internal audits.
  2. FY2021RestatedAnnual report

    「As the foundation of our system for ensuring that subsidiaries conduct their operations appropriately, each company generally holds a board meeting once a month, as well as extraordinary board meetings as necessary.」

    The company has reaffirmed its group management framework, including monthly board meetings, monthly financial reporting, overseas dispatches, visits by the president and J-SOX audits, for management of the group including overseas subsidiaries.
  3. FY2020MitigatedAnnual report

    「In addition, the President and Representative Director reports to the Board of Directors based on the monthly financial reports received from subsidiaries. Where necessary, directors are also dispatched overseas to become directly involved in management, and the President and Representative Director visits one of the subsidiaries each month.」

    Regarding the risk of managing overseas subsidiaries, the company described specific control systems, including monthly financial reporting, dispatch of directors, monthly visits by the president and J-SOX audits.
  4. FY2017First statedAnnual report

    「We operate efficiently by delegating a certain level of authority to subsidiaries. However, delegation of authority may also make it difficult to fully implement growth strategies and management control systems, potentially affecting our group’s operating performance and financial condition.」

    The company stated the risk that, in a group generating approximately 70% of sales overseas, it may be challenging to balance delegation of authority to regional subsidiaries with control by headquarters.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for ReproCELL yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.